NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/14/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization279.17 mln
Float10.20 mln
Earnings Date10/29/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.67
Likely reliable
1-Year Forecast
21.00
Fairly priced
Relative Strength
78
/ 100
Strongly outperforming
Debt / Equity
0.18
Very low leverage
Pre-Tax Margin
-2%
Barely loss-making
Business Description
Anika Therapeutics, founded in 1983 and based in Bedford, Massachusetts, develops products designed to protect joints and reduce the need for invasive procedures by addressing orthopedic conditions at an early stage. The company offers a range of treatments for osteoarthritis pain, including injection-based therapies and bone repair solutions, as well as products that support cartilage and tissue regeneration. Beyond orthopedics, Anika also markets treatments for surgical adhesion prevention, eye care, and joint health in horses. Its products are sold across the United States, Europe, and other international markets.
